Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Published: 01 September 2020

  • Views:

    Views Icon 56

  • Likes:

    Heart Icon 7
  • episode_image
    13m 38s
    Part 5 Q&As
    Kurt Huber, Davide Capodanno, Stefan James, Roxana Mehran
Average (ratings)
No ratings
Your rating

Overview

In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

  • Review the clinical landscape for antiplatelet therapy in patients with ACS.
  • Discuss recent data on DAPT for patients with ACS
  • Provide expert insight on application in routine clinical practice

More from this programme

Part 1

Welcome

1 session
Welcome Watch now

Part 2

Pre-treatment in NSTE-ACS – Dead or Alive?

1 session
Pre-treatment in NSTE-ACS – Dead or Alive? Watch now

Part 3

Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials

1 session
Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials Watch now

Part 4

When to leave Aspirin behind?

1 session
When to leave Aspirin behind? Watch now

Part 5

Q&As

1 session
Q&As Watch now

Faculty Biographies

Roxana Mehran

Roxana Mehran

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.

Dr. Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper…

View full profile